Skip to main content
Premium Trial:

Request an Annual Quote

Celera to Buy Bone Marrow Dx Company Atria Genetics for $33M

This article has been updated from a previous version, which incorrectly identified the location of Atria's headquarters.
NEW YORK (GenomeWeb News) - Celera said today that it plans to acquire Atria Genetics in a $33 million cash deal that is expected to add transplant-related testing to the company’s molecular diagnostics portfolio.
Celera expects the acquisition to close during its second fiscal quarter, which ends Dec. 31. The company expects the deal to be accretive to earnings by the second half of its 2008 fiscal year, which ends June 30, 2008.
Atria, based in South San Francisco, Calif., makes a line of human leukocyte antigen testing products designed to identify potential donors for bone marrow transplantations, Celera said.
The companies have an existing relationship: In 2004, Abbott Molecular began distributing Atria’s HLA sequencing products through its alliance with Celera.
Celera said today that the HLA market is around $175 million, of which around $20 million comes from bone marrow transplantation and the bone marrow registry.
Celera’s president, Kathy Ordoñez, said the Atria acquisition “gives us direct access to this important niche market area of tissue typing in transplantation and the bone marrow registry markets.”
Celera said it will integrate Atria’s 13 employees into its ranks.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.